Similar articles

• Total artificial heart as a bridge to retransplantation in acute cardiac rejection.

  Loisance DY, Deleuze P, Kawasaki K, Hillion ML, Binhas M, Heurtematte P, Tavolaro O, Leandri J, Cachera JP. Loisance DY, et al. J Heart Transplant. 1987 Sep-Oct;6(5):281-5. J Heart Transplant. 1987. PMID: 3316552
• Adverse outcomes from the use of older donor hearts in cardiac transplant recipients: the pros and cons of expanded donor criteria.

  Eisen HJ. Eisen HJ. J Am Coll Cardiol. 2004 May 5;43(9):1562-4. doi: 10.1016/j.jacc.2004.02.005. J Am Coll Cardiol. 2004. PMID: 15120812 No abstract available.
• Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list; Implications for donor selection criteria.

  Lietz K, John R, Mancini DM, Edwards NM. Lietz K, et al. J Am Coll Cardiol. 2004 May 5;43(9):1553-61. doi: 10.1016/j.jacc.2004.02.002. J Am Coll Cardiol. 2004. PMID: 15120811
• Retransplantation after renal allograft loss due to noncompliance. Indications, outcome, and ethical concerns.

  Troppmann C, Benedetti E, Gruessner RW, Payne WD, Sutherland DE, Najarian JS, Matas AJ. Troppmann C, et al. Transplantation. 1995 Feb 27;59(4):467-71. Transplantation. 1995. PMID: 7878747 Review.
• Of mice and men: mouse models and the molecular mechanisms of post-transplant coronary artery disease.

  George JF, Pinderski LJ, Litovsky S, Kirklin JK. George JF, et al. J Heart Lung Transplant. 2005 Dec;24(12):2003-14. doi: 10.1016/j.healun.2005.06.008. Epub 2005 Nov 14. J Heart Lung Transplant. 2005. PMID: 16364842 Review. No abstract available.